BridgeBio

Acoramidis

Early-Stage Variant Transthyretin Amyloidosis (ATTRv)

1. Preclinical
2. Phase 1
3. Phase 2
4. Phase 3
5. Approved

BBP-418

Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9)

1. Preclinical
2. Phase 1
3. Phase 2
4. Phase 3
5. Approved

Encaleret

Autosomal Dominant Hypocalcemia Type 1 (ADH1)

1. Preclinical
2. Phase 1
3. Phase 2
4. Phase 3
5. Approved

Chronic Hypoparathyroidism-NIH IIR

1. Preclinical
2. Phase 1
3. Phase 2
4. Phase 3
5. Approved

Infigratinib

Achondroplasia

1. Preclinical
2. Phase 1
3. Phase 2
4. Phase 3
5. Approved

Hypochondroplasia

1. Preclinical
2. Phase 1
3. Phase 2
4. Phase 3
5. Approved

BBP-812

Canavan Disease

1. Preclinical
2. Phase 1
3. Phase 2
4. Phase 3
5. Approved